Current status of cervical cancer and HPV infection in Korea.
- Author:
Young Tak KIM
1
Author Information
- Publication Type:Review
- Keywords: Cervical cancer; Human papillomavirus vaccines
- MeSH: Aged; Asia; Cervical Intraepithelial Neoplasia; Developing Countries; Early Detection of Cancer; Female; Financial Management; Human Papillomavirus DNA Tests; Humans; Korea; Mass Screening; Papillomavirus Vaccines; Prevalence; Risk Factors; Uterine Cervical Neoplasms; Vaccination; Vaginal Smears
- From:Journal of Gynecologic Oncology 2009;20(1):1-7
- CountryRepublic of Korea
- Language:English
- Abstract: Cervical cancer is an important cause of cancer-related deaths in women in developing countries. In Korea, cervical cancer is the third leading cancer among females and is fifth highest in mortality. The persistent oncogenic human papillomavirus (HPV) infections are the greatest risk of developing cervical intraepithelial neoplasia and invasive cancer. The overall prevalence of HPV was 10.4% in Korea and strong risk factors for HPV infection included a young age at sexual debut. The National Cancer Screening Program, which includes cervical cancer screening, has the following principles: the main screening tool is the Papanicolaou test conducted by gynecologists, which targets all women age 30 and over, and which is done every 2 years. HPV DNA tests have not yet been permitted as a screening test for cervical cancer in Korea; however, these are conducted along with a Pap test for screening cervical cancer in the clinic. The use of prophylactic HPV vaccine has been accepted in Korea; The Korean Society of Gynecologic Oncology and Colposcopy's recommendation for routine vaccination is for females aged 15-17 years with a catch-up vaccination recommended for females aged 18-26 years who have not been previously vaccinated. However, many people in Korea are not familiar with the HPV vaccine. Therefore, it is necessary to improve awareness for the disease and HPV vaccination and to establish the effective strategies to obtain funding for HPV vaccination. In the future, cervical cancer is expected to disappear throughout the world, including the Asia Pacific region, through a combination of vaccination and qualified screening programs for cervical cancer.
